Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

Using patient-derived B cells, Kling-Select facilitates the rapid detection of new antibodies and preserved viral epitopes.

Dutch privately-held biotech Kling Bio today announced it has entered into a collaboration and license option agreement with French pharma major Sanofi for the discovery of antibodies and epitopes ...

Kling Bio has announced a new collaboration and licence option agreement with Sanofi to accelerate the discovery of neutralising antibodies using its proprietary B cell platform, Kling-Select.

Investing.com -- Sanofi (NASDAQ: SNY) has started shipping its flu vaccine portfolio for the 2025-2026 season to health facilities across the United States, the company announced today. The vaccine ...

Investing.com -- Sanofi (EPA: SASY) (NASDAQ: SNY) has started shipping its flu vaccine portfolio for the 2025-2026 season to health facilities across the United States, the company announced today.

US pharma major AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation today announced an exclusive licensing agreement for IGI's lead investigational ...

Canyon County Clerk Rick Hogaboam is running for Nampa mayor with current Mayor Kling's endorsement. What issues would you like to see addressed in Nampa's future as the city continues to grow?